| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 22 |
| 1 | PREDNISONE | 21 |
| 2 | ACETAMINOPHEN 500MG | 19 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 19 |
| 4 | PAIN RELIEVER | 19 |
| 5 | RITUXIMAB | 16 |
| 6 | TOCILIZUMAB | 15 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 13 |
| 8 | METHOTREXATE SODIUM | 12 |
| 9 | METHYLPREDNISOLONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | 1 | 0.0370 |
| 1 | PEGUNIGALSIDASE ALFA | 1 | 0.0027 |
| 2 | TENECTEPLASE | 3 | 0.0019 |
| 3 | HEMIN | 1 | 0.0017 |
| 4 | IDURSULFASE | 6 | 0.0015 |
| 5 | DALBAVANCIN | 1 | 0.0010 |
| 6 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 7 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 8 | SIPULEUCEL-T | 2 | 0.0003 |
| 9 | TELMISARTAN | 6 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 33 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 15 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 5 | Vitamin B12 [EPC] | 10 |
| 6 | Vitamin C [EPC] | 10 |
| 7 | Vitamin D [EPC] | 10 |
| 8 | Calcium [EPC] | 9 |
| 9 | Benzodiazepine [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 7 | 0.0005 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 2 | 0.0003 |
| 2 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 15 | 0.0001 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 28 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 7 | 0.0001 |